Welcome to LookChem.com Sign In|Join Free
  • or
(S)-N-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (4-pentylphenyl)amide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

862506-77-2

Post Buying Request

862506-77-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

862506-77-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 862506-77-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,5,0 and 6 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 862506-77:
(8*8)+(7*6)+(6*2)+(5*5)+(4*0)+(3*6)+(2*7)+(1*7)=182
182 % 10 = 2
So 862506-77-2 is a valid CAS Registry Number.

862506-77-2Relevant academic research and scientific papers

Discovery of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid diamides that increase CFTR mediated chloride transport

Hirth, Bradford H.,Qiao, Shuang,Cuff, Lisa M.,Cochran, Brian M.,Pregel, Marko J.,Gregory, Jill S.,Sneddon, Scott F.,Kane Jr., John L.

, p. 2087 - 2091 (2007/10/03)

A series of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid diamides that increase chloride transport in cells expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein has been identified from our compound library. Analoging efforts and the resulting structure-activity relationships uncovered are detailed. Compound potency was improved over 30-fold from the original lead, yielding several analogs with EC50 values below 10 nM in our cellular chloride transport assay.

Tetrahydroisoquinoline derivatives for treating protein trafficking diseases

-

Page/Page column 11, (2008/06/13)

Tetrhydroisoquinoline derivatives, pharmaceutical compositions comprising them and methods of treating disease are disclosed herein. The disclosed compounds are useful in the treatment and prevention of diseases mediated by chloride channel activity and/or protein trafficking, including, but not limited to, diseases associated with impaired mucociliary clearance such as cystic fibrosis, bronchitis, emphysema, and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 862506-77-2